164 related articles for article (PubMed ID: 10346284)
1. Regulation of health-related technologies in Germany.
Perleth M; Busse R; Schwartz FW
Health Policy; 1999 Jan; 46(2):105-26. PubMed ID: 10346284
[TBL] [Abstract][Full Text] [Related]
2. Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences.
Tsoi B; Masucci L; Campbell K; Drummond M; O'Reilly D; Goeree R
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):497-511. PubMed ID: 23977976
[TBL] [Abstract][Full Text] [Related]
3. Health technology assessment in Germany. Status, challenges, and development.
Perleth M; Busse R
Int J Technol Assess Health Care; 2000; 16(2):412-28. PubMed ID: 10932416
[TBL] [Abstract][Full Text] [Related]
4. Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective.
Cookson R; Hutton J
Health Policy; 2003 Feb; 63(2):167-78. PubMed ID: 12543529
[TBL] [Abstract][Full Text] [Related]
5. [Licensing of Pharmaceuticals and Medical Devices in Germany: Weaknesses and Opportunities].
Reinhardt D; Wildner M
Gesundheitswesen; 2016 Dec; 78(12):844-852. PubMed ID: 28008577
[No Abstract] [Full Text] [Related]
6. Evidence-based decision on medical technologies in Asia Pacific: experiences from India, Malaysia, Philippines, and Pakistan.
Thatte U; Hussain S; de Rosas-Valera M; Malik MA
Value Health; 2009; 12 Suppl 3():S18-25. PubMed ID: 20586975
[TBL] [Abstract][Full Text] [Related]
7. [Marketing approval and market surveillance of medical devices in Germany: Where does policy integration take place?].
Lang A
Z Evid Fortbild Qual Gesundhwes; 2014; 108(5-6):320-4. PubMed ID: 25066351
[TBL] [Abstract][Full Text] [Related]
8. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
9. [Assessment of the benefit of medical devices in surgical practice. Problems and possible solutions].
Seidel D; Braß P; Sehnke N; Jakob V; Eglmeier W; Neugebauer EA;
Chirurg; 2014 May; 85(5):407-15. PubMed ID: 24402570
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of innovations in clinical research: strengths and potentials for improvement of research in Germany].
Vollmar HC; Georgieff P; Bührlen B
Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):738-43. PubMed ID: 21147437
[TBL] [Abstract][Full Text] [Related]
11. Health technology assessment and comparative effectiveness research: a pharmaceutical industry perspective.
Hao Y; Thomas A
Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):447-54. PubMed ID: 23977973
[TBL] [Abstract][Full Text] [Related]
12. Insurance coverage for experimental technologies.
Steinberg EP; Tunis S; Shapiro D
Health Aff (Millwood); 1995; 14(4):143-58. PubMed ID: 8690340
[TBL] [Abstract][Full Text] [Related]
13. Prescribing outside the limits of marketing authorizations and reimbursement by the French universal health insurance system.
Avouac B
Joint Bone Spine; 2002 Dec; 69(6):534-7. PubMed ID: 12537259
[No Abstract] [Full Text] [Related]
14. [Jurisdictions on the reimbursement of new medical technologies by public health insurance: A systematic review].
Ex P; Felgner S; Henschke C
Z Evid Fortbild Qual Gesundhwes; 2018 Apr; 131-132():8-16. PubMed ID: 29331280
[TBL] [Abstract][Full Text] [Related]
15. Balancing adoption and affordability of medical devices in Europe.
Schreyögg J; Bäumler M; Busse R
Health Policy; 2009 Oct; 92(2-3):218-24. PubMed ID: 19410326
[TBL] [Abstract][Full Text] [Related]
16. [Shockwaves in plantar fasciitis without effect. Apparently a "hard" indication qualfies].
Hakimi R
MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652933
[No Abstract] [Full Text] [Related]
17. Regulating biotechnology: a rational-political model of policy development.
Wiktorowicz M; Deber R
Health Policy; 1997 May; 40(2):115-38. PubMed ID: 10167067
[TBL] [Abstract][Full Text] [Related]
18. The 21st Century Cures Act and Early Feasibility Studies for Cardiovascular Devices: What Have We Learned, Where Do We Need to Go?
Holmes DR; Hance R; Syrek Jensen TS; Schwartz DA; Kaplan A; Farb A; Zuckerman B; Leon M; Waklowiak J; Mack MJ; Shuren J
JACC Cardiovasc Interv; 2018 Nov; 11(21):2220-2225. PubMed ID: 30409280
[TBL] [Abstract][Full Text] [Related]
19. [The medical advisory services of social health insurance].
Hansis ML
Zentralbl Chir; 2002 Dec; 127(12):1083-5. PubMed ID: 12529825
[TBL] [Abstract][Full Text] [Related]
20. The limited state of technology assessment for medical devices: facing the issues.
Ramsey SD; Luce BR; Deyo R; Franklin G
Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
